A pharmacy licence, patient-specific prescription or 503B registration is not the complete route assessment. FDA distinguishes the conditions applicable to 503A and 503B, including prescription requirements, bulk-substance restrictions and restrictions on essentially copied products. (fda.gov)
Answers stay in this session unless you choose to save. No account needed.
Evidence to attach: the route diagram, dated assessment, source references and relevant approvals. For a compounded preparation, include the actual formulation and the supplier’s stated legal basis—not a generic 503A/503B brochure.
If you score 0–1: use a Before-You-Sign Supply-Route Screen to prepare a focused specialist review. Do not present the arrangement as a qualified savings opportunity.
Sources cited on this page
- fda.gov · Source 1 ↗https://www.fda.gov/drugs/human-drug-compounding/fdc-act-provisions-apply-human-drug-compounding